The company’s website is empty, displaying a logo on a teal background. The business was formed in January 2020, and it doesn’t operate in other states.
Natures GA is an affiliate of Nature’s Medicines, which operates in six states. Natures GA was the only winning applicant that filed its 774-page application without many redactions.
Another company, Fine Fettle, operates dispensaries in Connecticut and Massachusetts but doesn’t currently manufacture medical marijuana oil. It plans to do business in Macon.
“There’s a risk they will not be as ready on day one as the companies that have been doing this for a decade and operating in several states,” Hudak said. “If the newer companies look around at the industry, talk to people and oftentimes hire people from other companies, they’ll begin to understand quickly what is necessary to make this work.”
But its CEO is an Atlanta doctor specializing in pain management, and its board of directors includes former U.S. Rep. Tom Price, a Republican who voted against medical marijuana bills in Congress and briefly served as President Donald Trump’s health secretary.
Schweich said that the organization’s reasoning is hypocritical given that alcohol and nicotine are permitted by WADA even though they have similar effects on the body.
“Medical and nonmedical cannabis use among athletes reflects changing societal and cultural norms and experiences,” researchers wrote in their conclusion.
“America is the birthplace of harsh cannabis policies and like many things we exported it around the world,” Matthew Schweich, the deputy director of the nonprofit group the Marijuana Policy Project, told ABC News. “There’s a lot that needs to be undone.”
Although the 21-year-old told reporters she used marijuana during the Olympic trials in Oregon, which has legalized the substance for recreational use, as a way to cope with the loss of her birth mother, the U.S. Anti-Doping Agency suspended her for 30 days citing the World Anti-Doping Agency’s ban on cannabis.
Schweich said WADA’s research on cannabis’ effect on performance is questionable given other studies in recent years. A 2018 study published in The Clinical Journal of Sport Medicine found “no evidence for cannabis use as a performance-enhancing drug.”
The paper’s researchers looked at data from previous studies on cannabis in sports dating as far back as the 1960s. They did not take into account the number of participants in each previous study nor the magnitude of effect within each individual study when making their conclusions.
In 2011, WADA published a paper in Sports Medicine explaining why marijuana fit all three criteria. As a performance enhancer, the paper stated the substance “reduces anxiety, allowing athletes to better perform under pressure.” For risk to health, the paper said marijuana causes “slower reaction times and poor executive function or decision making.” And as a sign of it being against the spirit of sport the paper said it’s “not consistent with the athlete as a role model for young people around the world.”